BNGO: Bionano PEG multiplikatori
Bionano Genomics, Inc. (BNGO) xarajatlarni kamaytirish orqali zararsiz nuqtaga erishishga intilmoqda va OGM tsitogenetika standarti sifatida tan olinishi hamda sug'urta to'lovlarini ta'minlashini kutmoqda. O'sish ko'rsatkichi nisbatan past baholanganligi aktivlar dinamikasini aks ettiradi, bunda 0.00 ushbu metrikaning darajasini ko'rsatadi. Biznes asosini AI tahlili va sarflanadigan chiplarni integratsiya qilgan, mijozlar sodiqligini ta'minlovchi yopiq Saphyr ekotizimi tashkil etadi.
Bionano Genomics, Inc. (BNGO) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Bionano Genomics, Inc.|BNGO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning o'z kapitaliga nisbati bionanogenomics.com|BNGO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Bionano|BNGO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Bionano Genomics|Shoshilinch likvidlik bionanogenomics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
BNGO - Kompaniyaning sof foydasi|Kelajakdagi foyda Bionano Genomics, Inc.|BNGO - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati bionanogenomics.com|BNGO - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Bionano|BNGO - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Bionano Genomics|BNGO - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi bionanogenomics.com|BNGO - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Bionano Genomics, Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:BNGO - Bionano Genomics Inc.
Ushbu ko'rsatkich aktivlarning stress-testlari uchun muhim filtr vazifasini o'tab, yuqori kengayish potentsialiga ega bo'lgan past baholangan kompaniyalarni aniqlash imkonini beradi. O'sishga moslashtirilgan P/E ko'rsatkichidagi P/E multiplikatorining foyda o'sish sur'atlariga nisbati Bionano Genomics, Inc. (BNGO) baholanishi global genetik markazlarda Saphyr tizimlarining tijorat muvaffaqiyati bilan qanchalik asoslanganligini ko'rsatadi, bu yerda DNK xaritalashiga bo'lgan talab kelgusidagi kapitalizatsiyani belgilaydi.
Bionano Genomics, Inc. raqobatchilari
Tempus AI, Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori QGEN (Qiagen Group)|PEG multiplikatori Isis Pharmaceuticals IONS|RGEN - Narxning foydaga va o‘sish sur’atiga nisbati|RNA (aviditybiosciences.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|CRISPR Therapeutics (CRSP) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda GeneDx Holdings (WGS)|Narx-foyda va o‘sish multiplikatori RARE|BEAM: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SRPT|twistbioscience.com (TWST) - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori TXG (10x Genomics)|Intellia Therapeutics Inc (NTLA) - O‘sish sur’atiga tuzatilgan narx-foyda|STOK - Narxning foydaga va o‘sish sur’atiga nisbati|BLFS (BioLife) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Wave Life Sciences (WVE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda mazetx.com (MAZE)|Narxning foydaga va o‘sish sur’atiga nisbati Sionna Therapeutics|Narx-foyda va o‘sish multiplikatori Prime Medicine Inc (PRME)|PEG multiplikatori TSHA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati uniQure Pharma|PEG multiplikatori MGTX (MeiraGTx Holdings plc)|RGNX - Narx-foyda va o‘sish multiplikatori|SLDB - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ocugen Inc OCGN|PACB (Pacific Biosciences of California) - Narx-foyda va o‘sish multiplikatori|Benitec Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|DSGN (Design Therapeutics) - PEG multiplikatori|rocketpharma.com (RCKT) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati 4D Molecular Therapeutics, Inc. (FDMT)|lexeotx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori KRRO (Korro Bio)|EDIT - Narx-foyda va o‘sish multiplikatori|SLN: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati ProQR Therapeutics N.V. PRQR|CDXS: PEG multiplikatori|SGMO (Sangamo Therapeutics Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Nautilus Biotechnology, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti MGX (Metagenomi Therapeutics)|PEG multiplikatori DTIL|generationbio.com (GBIO) - Narxning sof foyda o‘sishiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Boundless Bio BOLD|Exicure Inc. (XCUR) - O‘sish sur’atiga tuzatilgan narx-foyda|Celsion Corporation - PEG multiplikatori|PHIO (Phio Pharmaceuticals) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|mustangbio.com (MBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti RNAZ|APDN (Applied DNA Sciences, Inc.) - PEG multiplikatori|PEG multiplikatori bluebird bio Inc.|PEG multiplikatori IPA|Narxning foydaga va o‘sish sur’atiga nisbati OMGA (Omega Therapeutics Corp)|PEG multiplikatori OMIC (Singular Genomics Systems)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati regulusrx.com (RGLS)|SYRS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Telesis Bio Inc.|TRACON (TCON) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti UBX
